Arindam Mondal

Arindam Mondal

Rutgers, The State University of New Jersey

H-index: 14

North America-United States

About Arindam Mondal

Arindam Mondal, With an exceptional h-index of 14 and a recent h-index of 13 (since 2020), a distinguished researcher at Rutgers, The State University of New Jersey, specializes in the field of Lung Cancer, BMPR2, Molecular Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Combining BMP inhibitors with mitochondria targeting agents has potential to treat lung cancer

Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells

Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells

Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans

Bone morphogenetic protein receptor inhibitors suppress the growth of glioblastoma cells

Telmisartan facilitates the anticancer effects of CARP-1 functional mimetic and sorafenib in rociletinib resistant non-small cell lung cancer

Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells

Polysaccharide hydrogel based 3D printed tumor models for chemotherapeutic drug screening

Arindam Mondal Information

University

Position

___

Citations(all)

646

Citations(since 2020)

531

Cited By

279

hIndex(all)

14

hIndex(since 2020)

13

i10Index(all)

17

i10Index(since 2020)

15

Email

University Profile Page

Rutgers, The State University of New Jersey

Google Scholar

View Google Scholar Profile

Arindam Mondal Skills & Research Interests

Lung Cancer

BMPR2

Molecular Biology

Top articles of Arindam Mondal

Title

Journal

Author(s)

Publication Date

Combining BMP inhibitors with mitochondria targeting agents has potential to treat lung cancer

Arindam Mondal

Jacques Roberge

John Gilleran

Youyi Peng

Dongxuan Jia

...

2023/4/14

Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells

Scientific reports

Arindam Mondal

Dongxuan Jia

Vrushank Bhatt

Moumen Akel

Jacques Roberge

...

2022/7/30

Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells

Cell Communication and Signaling

Arindam Mondal

Jacques Roberge

John Gilleran

Youyi Peng

Dongxuan Jia

...

2022/6/27

Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans

Cell & Bioscience

Mehul Vora

Arindam Mondal

Dongxuan Jia

Pranya Gaddipati

Moumen Akel

...

2022/5/31

Bone morphogenetic protein receptor inhibitors suppress the growth of glioblastoma cells

Molecular and cellular biochemistry

Joel Kaye

Arindam Mondal

Ramsey Foty

Dongxuan Jia

John Langenfeld

2022/5

Telmisartan facilitates the anticancer effects of CARP-1 functional mimetic and sorafenib in rociletinib resistant non-small cell lung cancer

Anticancer research

Sunil Kumar Surapaneni

Ebony Nottingham

Arindam Mondal

Nilkumar Patel

Peggy Arthur

...

2021/9/1

Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells

Materials Science and Engineering: C

Mariza Abreu Miranda

Priscyla Daniely Marcato

Arindam Mondal

Nusrat Chowdhury

Aragaw Gebeyehu

...

2021/2/1

Polysaccharide hydrogel based 3D printed tumor models for chemotherapeutic drug screening

Scientific reports

Aragaw Gebeyehu

Sunil Kumar Surapaneni

John Huang

Arindam Mondal

Vivian Ziwen Wang

...

2021/1/11

Curcumin and Afatinib Synergistically Inhibit Growth of Human Osteosarcoma Cells by Inhibition of Matrix Metallo Proteinases, Mitogen Activated kinases 1-4, and Reactive Oxygen …

Journal of Pharmacy and Drug Development

Lunawati L Bennett

Arindam Mondal

2021

Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells

Cell communication and signaling

Arindam Mondal

Rachel NeMoyer

Mehul Vora

Logan Napoli

Zoya Syed

...

2021/12

Synergistic effects of methyl 2-cyano-3, 11-dioxo-18beta-olean-1,-12-dien-30-oate and erlotinib on erlotinib-resistant non-small cell lung cancer cells

Journal of Pharmaceutical Analysis

Ebony Nottingham

Elizabeth Mazzio

Sunil Kumar Surapaneni

Shallu Kutlehria

Arindam Mondal

...

2021/12/1

The role of Self-Nanoemulsifying drug delivery systems of CDODA-Me in sensitizing Erlotinib-Resistant non–small cell lung cancer

Journal of pharmaceutical sciences

Ebony Nottingham

Vasanthakumar Sekar

Arindam Mondal

Stephen Safe

Arun K Rishi

...

2020/6/1

Bone morphogenetic protein (BMP) receptor inhibitor JL5 synergizes with Ym155 to induce AIF-caspase independent cell death.

A Mondal

R NeMoyer

E Langenfeld

D Glover

M Scott

...

2020/4/1

Author Correction: Characterization and printability of Sodium alginate-Gelatin hydrogel for bioprinting NSCLC co-culture

Scientific Reports

Arindam Mondal

Aragaw Gebeyehu

Mariza Miranda

Divya Bahadur

Nilkumar Patel

...

2020

Targeting lung cancer stem cells using combination of Tel and Docetaxel liposomes in 3D cultures and tumor xenografts

Toxicology and applied pharmacology

Peggy Arthur

Nilkumar Patel

Sunil Kumar Surapaneni

Arindam Mondal

Aragaw Gebeyehu

...

2020/8/15

See List of Professors in Arindam Mondal University(Rutgers, The State University of New Jersey)